Vascular dementia: A contemporary review of epidemiology, diagnosis, prevention, and treatment

Journal of the American Geriatrics Society

Volumn 46, Issue 11, 1998, Pages 1437-1448

  Nyenhuis, David L ^a,b   Gorelick, Philip B ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Center for Stroke Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NIMODIPINE; PENTOXIFYLLINE;

ALZHEIMER DISEASE; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; HUMAN; MULTIINFARCT DEMENTIA; NEUROPROTECTION; PREVALENCE; PRIMARY PREVENTION; REVIEW; RISK FACTOR; SMOKING CESSATION; STROKE; TREATMENT PLANNING;

EID: 0031759672     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb06015.x     Document Type: Review

References (147)

1. Whitehouse PJ, Lerner A, Hedera P. Dementia. In: Heilman KM, Valenstein E, eds. Clinical Neuropsychology, 3rd Ed. New York: Oxford University Press, 1993, pp 603-646.
2. Gorelick PB, Roman G, Mangone CA. Vascular dementia. In: Gorelick PB, Alter MA, eds. Handbook of Neuroepidemiology. New York: Marcel Dekker, 1994, pp 197-214.
3. Brust JCM. Vascular dementia is overdiagnosed. Arch Neurol 1988;45: 799-801.
4. O'Brien MD. Vascular dementia is underdiagnosed. Arch Neurol 1988;45: 797-798.
5. Hulette C, Nochlin D, McKeel D et al. Clinical-neuropathological findings in multi-infarct dementia: A report of six autopsied cases. Neurology 1997; 48:668-672.
6. Tatemichi TK. How acute brain failure becomes chronic: A view of the mechanisms of dementia related to stroke. Neurology 1990;40:1652-1659.
7. Hachinski VC, Bowler JV. Vascular dementia. Neurology (letter) 1993;43: 2159-2160.
8. Udea K, Hasuo Y, Fujishima M. Prevalence and etiology of dementia in a Japanese community. Stroke 1992;23:798-803.
9. Kondo K. Senile dementias: Epidemiology and its applications. In: Kondo K, Kanamori M, Kawamura S et al., eds. Neurology and Public Health in Japan. Geneva: World Health Organization Publication, 1997, pp 227-234.
10. Gorelick PB, Nyenhuis DL, Garron DC, Cochran E. Is vascular dementia really Alzheimer's disease or mixed dementia? Neuroepidemiology 1996; 15:286-290.
11. Skoog I, Nilsson L, Palmertz B et al. A population-based study of dementia in 85-year olds. N Engl J Med 1993;328:153-158.
12. Gorelick PB, Freels S, Harris Y et al. Epidemiology of vascular and Alzheimer's dementia among African Americans in Chicago, IL: Baseline frequency and comparison of risk factors. Neurology 1994;44:1391-1396.
13. Hagnell O, Ojesjo L, Rorsman B. Incidence of dementia in the Lundby Study. Neuroepidemiology 1992;11(suppl 1):61-66.
14. Schoenberg BS, Kokeman E, Okazaki H. Alzheimer's disease and other dementing illnesses in a defined United States population: Incidence rates and clinical features. Ann Neurol 1987;22:724-729.
15. Molsa PK, Martilla RJ, Rinne UK. Epidemiology of dementia in a Finnish population. Acta Neurol Scand 1982;65:541-552.
16. Launer LJ. Overview of incidence studies of dementia conducted in Europe. Neuroepidemiology 1992;11(suppl 1):2-13.
17. Rocca WA, Hofman A, Brayne C et al. The prevalence of vascular dementia in Europe: Facts and fragments from 1980-1990 studies. Ann Neurol 1991;30:817-824.
18. Tatemichi TK, Paik M, Bagiella E et al. Risk of dementia after stroke in a hospitalized cohort: Results of a longitudinal study. Neurology 1994;44: 1885-1891.
19. Censori B, Manara O, Agostinis C et al. Dementia after first stroke. Stroke 1996;27:1205-1210.
20. Gorelick PB. Status of risk factors for dementia associated with stroke. Stroke 1997;28:459-463.
21. Skoog I. Status of risk factors for vascular dementia. Neuroepidemiology 1998;17:2-9.
22. Gorelick PB. Stroke prevention. Arch Neurol 1995;52:347-354.
23. Gorelick PB, Brody JA, Cohen DC et al. Risk factors for dementia associated with multiple cerebral infarcts: A case-control analysis in predominantly African American hospital-based patients. Arch Neurol 1993;50: 714-720.
24. Tatemichi TK, Desmond DW, Mayeux R et al. Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992;42:1185-1193.
25. Haan J, Lanser JBK, Zijderveld I et al. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type. Arch Neurol 1990;47:965-967.
26. Sourander P, Walinder J. Hereditary multi-infarct dementia: Morphological and clinical studies of a new disease. Acta Neuropathol (Berl) 1977;39:247-254.
27. Bousser MG, Tournier-Lasserve E. Summary of the proceedings of the First International Workshop on CADASIL. Stroke 1994;25:704-707.
28. Slooter AJC, Tang M-X, van Duijn CM et al. Apolipoprotein E e4 and the risk of dementia with stroke. A population-based investigation. JAMA 1997;277:818-821.
29. Yoshitake T, Kiyohara Y, Yato I et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a denned elderly Japanese population: The Hisayama Study. Neurology 1995;45:1161-1168.
30. Ladurner G, Iliff LD, Lechner H. Clinical factors associated with dementia in ischemic stroke. J Neurol Neurosurg Psychiatry 1982;45:97-101.
31. Ott A, Breteler MMB, de Bruyne MC et al. Atrial fibrillation and dementia in a population-based study: The Rotterdam Study. Stroke 1997;28:316-321.
32. Tatemichi TK, Desmond DW, Paik M et al. Clinical determinants of dementia related to stroke. Ann Neurol 1993;33:568-575.
33. Desmond DW, Tatemichi TK, Paik M, Stern Y. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol 1993;50:162-166.
34. Roman GC. From UBOs to Binswanger's disease: Impact of magnetic resonance imaging on vascular dementia research. Stroke 1996;27:1269-1273.
35. Tomlinson BE, Blessed G, Roth M. Observations of the brains of demented old people. J Neurol Sci 1970;11:205-242.
36. Loeb C, Gandolfo C, Bino G. Intellectual impairment and cerebral lesions in multiple cerebral infarcts: A clinical-computed tomography study. Stroke 1988;19:560-565.
37. Tatemichi TK, Foulkes MA, Mohr JP et al. Dementia in stroke survivors in the Stroke Data Bank cohort: Prevalence, incidence, risk factors and computed tomographic findings. Stroke 1990;21:858-866.
38. Gorelick PB, Chatterjee A, Patel D et al. Cranial computed tomographic observations in multi-infarct dementia: A controlled study. Stroke 1992;23: 804-811.
39. Gorelick PB, Budzenski C, Hier DB et al. Thalamic infarction: Neuropsychiatric, language and CT correlates. Neurology (Abstract) 1985;35(suppl 1):180.
40. Liu CK, Miller BL, Cummings JL. A quantitative MRI study of vascular dementia. Neurology 1992;42:138-143.
41. Charletta D, Gorelick PB, Dollear T et al. CT and MRI findings among African Americans with Alzheimer's disease, vascular dementia and stroke without dementia. Neurology 1995;45:1456-1461.
42. Hershey LA, Modic MT, Greenough PG, Jaffee DF. Magnetic resonance imaging in vascular dementia. Neurology 1987;37:29-36.
43. Hachinski VC, Potter P, Merskey H. Leukoaraiosis. Arch Neurol 1987;44: 21-23.
44. Chimowitz MI, Awad IA, Furlan AJ. Periventricular lesions on MRI: Facts and theories. Stroke 1989;20:963-967.
45. Chimowitz MI, Estes ML, Furlan AJ, Awad IA. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol 1992;49:747-752.
46. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: A review. Stroke 1997;28:652-659.
47. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Ann Neurol 1986;19:253-262.
48. Maroney JT, Bagiella E, Desmond DW et al. Risk factors for incident dementia after stroke: Role of hypoxic and ischemic disorders. Stroke 1996; 27:1283-1289.
49. Liao D, Cooper L, Cai J et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control: The ARIC Study. Stroke 1996;27:2262-2270.
50. Schmidt R, Hayn M, Fazekas F et al. Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals: Correlations with plasma concentrations of naturally occurring antioxidants. Stroke 1996;27:2043-2047.
51. Van Zagten M, Boiten J, Kessels F, Lodder J. Significant progression of white matter lesions and small deep (lacunar) infarcts in patients with stroke. Arch Neurol 1996;53:650-655.
52. Liao D, Cooper L, Cai J et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender and cardiovascular disease risk factors: The ARIC Study. Neuroepidemiology 1997;16:149-162.
53. Longstreth Jr WT, Manolio TA, Arnold A et al., for the Cardiovascular Health Study Collaborative Research Group. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The Cardiovascular Health Study. Stroke 1996;27:1274-1282.
54. Pullicino P, Benedict RHB, Capruso DX et al. Neuroimaging criteria for vascular dementia. Arch Neurol 1996;53:723-728.
55. Meyer JS, Takashima S, Obara K. 'Silent cerebrovascular lesions' occur among elderly 'normal' volunteers besides patients with previous symptomatic strokes. J Stroke Cerebrovasc Dis 1994;4:229-234.
56. Lindsay J, Hebert R, Rockwood K. The Canadian Study of Health and Aging: Risk factors for vascular dementia. Stroke 1997;28:526-530.
57. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
58. The World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization, 1993.
59. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997;337: 1667-1674.
60. Hachinski V. Preventable senility: A call for action against the vascular dementias. Lancet 1992;340:645-648.
61. Chui HC, Victoroff JI, Margolin D et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
62. Roman GC, Tatemichi TK, Erkinjuntii T et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-268.
63. Amar K, Wilcock G. Vascular dementia. Br Med J 1996;312:227-231.
64. Loeb C, Meyer JC. Vascular dementia: Still a debatable entity? J Neurol Sci 1996;143:31-40.
65. Roth M. The natural history of mental disorder in old age. J Ment Sci 1955;101:281-301.
66. Slater E, Roth M. Mental diseases in the aged. In: Mayer-Gross W, Slater E, Roth M, eds. Clinical Psychiatry, 3rd Ed. Baltimore: Williams & Wilkins, 1969, pp 593-596.
67. Hachinski VC, Iliff LD, Zilhka E et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
68. Blessed G, Slater E, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
69. Molsa PK, Paljarvi L, Rinne JO et al. Validity of clinical diagnosis in dementia: A prospective clinicopathological study. J Neurol Neurosurg Psychiatry 1985;48:1085-1090.
70. Rosen WG, Terry RD, Fuld PA et al. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1979;7:486-488.
71. Homer AC, Honaver M, Lantos PL et al. Diagnosing dementia: Do we get it right? Br Med J 1988;297:894-896.
72. Moroney JT, Bagiella E, Desmond DW et al. Meta-analysis of the Hachinski Ischemia Score in pathologically verified dementias. Neurology 1997; 49:1096-1105.
73. Bennett DA, Wilson RS, Gilley DW, Fox JH. Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry 1990;53:961-965.
74. O'Neill D, Gerrard J, Surmon D, Wilcock GK. Variability in scoring the Hachinski Ischemia Score. Age Aging 1995;24:242-246.
75. World Health Organization (WHO). The neurological adaptation of the International Classification of Diseases (ICD-10NA)(draft). Geneva: World Health Organization, 1991.
76. Lopez OL, Larumbe MR, Becker JT et al. Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology 1994;44: 1240-1245.
77. Wetterling T, Kanitz R-D, Borgis K-J. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996;27:30-36.
78. Verhey FRJ, Lodder J, Rozendaal N, Jolles J. Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 1996;15:166-172.
79. Gold G, Giannakopoulos P, Montes-Paixao C et al. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 1997;49:690-694.
80. Mirra SS, Heyman A, McKeel D et al. The Consortium to Establish a Registry for Alzheimer's disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
81. Pullicino PM, Alexandrov AV, Benedict R. Imaging criteria for vascular dementia. Neurology 1995;45:1424-1425.
82. Erkinjuntti T. Types of multi-infarct dementia. Acta Neurol Scand 1987; 75:391-99.
83. Caplan LR, Schoene WC. Clinical features of subcortical arteriosclerotic encephalopathy (Binswanger disease). Neurology 1978;28:1206-1215.
84. Bennett DA, Gilley DW, Lee S, Cochran EJ. White matter changes: Neurobehavioral manifestations of Binswanger's disease. Dementia 1994;5: 148-152.
85. Roman GC. The identity of lacunar dementia and Binswanger disease. Med Hypotheses 1985;16:389-391.
86. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia a cause of mental deterioration in the elderly. Lancet 1974;2:207-209.
87. Fischer P, Gatterer G, Marterer A et al. Course characteristics in the differentiation of dementia of the Alzheimer's type and multi-infarct dementia. Acta Psychiatr Scand 1990;81:551-553.
88. Zubenko GS. Progression of illness in the differential diagnosis of primary dementia. Am J Psychiatry 1990;147:435-438.
89. Nyenhuis DL, Gorelick PB, Freels S, Garron DC. Cognitive and functional decline in African-Americans diagnosed with vascular dementia or stroke without dementia. J Int Neuropsychol Soc (abstract) 1998;4:59.
90. Nyenhuis DL, Gorelick PB, Freels S, Garron DC. Relatively poor memory at baseline is associated with progressive cognitive decline in patients with cerebrovascular disease. J Int Neuropsychol Soc (Abstract)1997;3:66.
91. Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Assessment: Neuropsychological testing of adults-Considerations for neurologists. Neurology 1996;47:592-599.
92. Bogdanoff B, Gitlin H, Norman L et al. Neuropsychological comparisons between subjects with ischaemic vascular dementia, Parkinson's disease and Alzheimer's disease. Neurology (Abstract)1997;48:A231-232.
93. Fuld PA. Test profile of cholinergic dysfunction and Alzheimer-type dementia. J Clin Neuropsychol 1984;6:380-392.
94. Mendez MF, Ashla-Mendez MA. Differences between multi-infarct dementia and Alzheimer's disease on unstructured neuropsychological tasks. J Clin Exp Neuropsychol 1991;13:923-932.
95. Kontiola P, Laaksonen R, Sulkava R, Erkinjuntti T. Pattern of language impairment is different in Alzheimer's disease and multi-infarct dementia. Brain Lang 1990;38:364-383.
96. Starkstein SE, Sabe L, Vazquez S et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke 1996;27:408-414.
97. Crossley M, D'Arcy C, Rawson NSB. Letter and category fluency in community-dwelling Canadian seniors: A comparison of normal participants to those with dementia of the Alzheimer or vascular type. J Clin Exp Neuropsychol 1997;19:52-62.
98. Benthem PW, Jones S, Hodges JR. A comparison of semantic memory in vascular dementia and dementia of the Alzheimer type. Int J Geriatr Psychiatry 1997;12:575-580.
99. Villardita C. Alzheimer's disease compared with cerebrovascular dementia: Neuropsychological similarities and differences. Acta Neurol Scand 1993; 87:299-308.
100. Kertesz A, Clydesdale S. Neuropsychological deficits in vascular dementia vs Alzheimer's disease: Frontal lobe deficits prominent in vascular dementia. Arch Neurol 1994;51:1226-1231.
101. McPherson SE, Cummings JL. Neuropsychological aspects of vascular dementia. Brain Cogn 1996;31:269-282.
102. Gfeller JD, Rankin EJ. The WAIS-R profile as a cognitive marker of Alzheimer's disease: A misguided venture? J Clin Exp Neuropsychol 1991;13: 629-636.
103. Metter EJ, Wilson RS. Vascular dementia. In: Parks RW, Zee RF, Wilson RS, eds. Neuropsychology of Alzheimer's Disease and Other Dementias. New York: Oxford University Press, 1993, pp 416-437.
104. Libon DJ, Bogdanoff B, Cloud BS et al. Declarative and procedural learning, quantitative measures of the hippocampus, and subcortical white alterations in Alzheimer's disease and ischaemic vascular dementia. J Clin Exp Neuropsychol, 1998:20:30-41.
105. Lamar M, Podell K, Carew TG et al. Perseverative behavior in Alzheimer's disease and subcortical ischemic vascular dementia. Neuropsychology 1997;11:1-12.
106. Libon DJ, Mattson RE, Glosser G et al. A nine word dementia version of the California Verbal Learning Test. Clin Neuropsychol 1996;10:237-244.
107. Libon DJ, Bogdanoff B, Bonavita J et al. Dementia associated with periventricular and deep white matter alterations: A subtype of subcortical dementia. Arch Clin Neuropsychol 1997;12:239-250.
108. Goldberg E, Tucker D. Motor perseveration and long-term memory for visual forms. J Clin Neuropsychol 1979;1:273-288.
109. Eastwood MR, Rifat SL, Nobbs H, Ruderman J. Mood disorder following cerebrovascular accident. Br J Psychiatry 1989;154:195-200.
110. Robinson RG, Starr LB, Kubos KL, Price TR. A two-year longitudinal study of post-stroke mood disorders: Findings during the initial evaluation. Stroke 1983;14:736-741.
111. Sharpe M, Hawton K, House A et al. Mood disorders in long-term survivors of stroke: Associations with brain lesion location and volume. Psychol Med 1990;20:815-828.
112. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994;25:1099-1104.
113. Lauritzen L, Bendsen BB, Vilmar T et al. Post-stroke depression: Combined treatment with imipramine or desipramine and mianserin. A controlled clinical study. Psychopharmacology (Berl) 1994;114:119-122.
114. Lazarus LW, Moberg PJ, Langsley PR, Lingam VR. Methyphenidate and nortryptiline in the treatment of poststroke depression: A retrospective comparison. Arch Phys Med Rehabil 1994;75:403-406.
115. Lipsey JR, Robinson RG, Pearlson GD et al. Nortryptiline treatment of post stroke depression. Lancet 1984;1:297-300.
116. Gilley DW, Wilson RS, Stebbins GT. Validity of the Geriatric Depression Scale in Alzheimer's disease. J Clin Exp Neuropsychol (Abstract) 1992;14: 20.
117. Nyenhuis DL, Stern RA, Yamamoto C, Terrien A, Parmentier A, Luchetta T, Arruda JE. Standardization and validation of the Visual Analog Mood Scales. Clin Neuropsychol 1997;11:407-415.
118. Bernard BA, Wilson RS, Gilley DW et al. Performance of patients with BD and AD on the Mattis dementia rating scale. J Clin Exp Neuropsychol (abstract) 1990;12:22.
119. Cummings JL, Miller B, Hill MA, Neshkes R. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer's type. Arch Neurol 1987;44:389-393.
120. Bernard BA, Wilson RS, Gilley DW et al.0 Affective and behavioral symptoms in African-Americans with Alzheimer's disease or vascular dementia. J Ment Health Aging, 1998;4:97-104.
121. Sultzer DL, Levin HS, Mahler ME et al. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry 1993; 150:1806-1812.
122. Tomlinson BE, Henderson G. Some quantitative cerebral findings in normal and demented old people. In: Terry RD, Gershon S, eds. Neurology of Aging. New York: Raven Press, 1976, pp 183-204.
123. del Ser T, Bermejo F, Portera A et al. Vascular dementia: A clinicopathological study. J Neurol Sci 1990;96:1-17.
124. Munoz DG. The pathological basis of multi-infarct dementia. Alzheimer Dis Assoc Disord 1991;5:77-90.
125. Olsson Y, Brun A, Englund E. Fundamental pathological lesions in vascular dementia. Acta Neurol Scand 1996;168(suppl):31-38.
126. Erkinjuntii T, Benavente O, Eliasziw M et al. Diffuse vacuolization (spongiosis) and arteriosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol 1996;53:325-332.
127. Hansen LA. Pathology of the other dementias. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer Disease. New York: Raven Press, 1994, pp 172.
128. Terry RD, Maslah E, Hansen LA. Structural basis of the cognitive alterations in Alzheimer disease. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer Disease. New York: Raven Press, 1994, pp 187-188.
129. Whisnant JP. Modeling of risk factors for ischemic stroke: The Willis lecture. Stroke 1997;28:1839-1843.
130. Skoog I, Lernfelt B, Landahl S et al. 15-year longitudinal study of blood pressure and dementia Lancet 1996;347:1141-1145.
131. Launer LJ, Masaki K, Petrovich H et al. The association between midlife blood pressure levels and late-life cognitive function: The Honolulu-Asia Aging Study. JAMA 1995;274:1846-1851.
132. Okumiya K, Matsubayashi K, Wada T et al. J-curve relation between blood pressure and decline in cognitive function in older people living in the community, Japan. Lancet (letter)1997;45:1032-1033.
133. Farmer ME, White LR, Abbott RD et al. Blood pressure and cognitive performance: The Framingham Study. Am J Epidemiol 1987;126:1103-1114.
134. Elias MF, Wolf PA, D'Agostino RB et al. Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study. Am J Epidemiol 1993;138:353-364.
135. Scherr PA, Hebert LE, Smith LA, Evans DA. Relation of blood pressure to cognitive function in the elderly. Am J Epidemiol 1991;134:1303-1315.
136. Bird AS, Blizard RA, Mann AH. Treating hypertension in the older person: An evaluation of the association of blood pressure level and its reduction with cognitive performance. J Hypertens 1990;8:147-152.
137. Battersby C, Hartley K, Fletcher AE et al. Cognitive function in hypertension: A community based study. J Hum Htn 1993;7:117-123.
138. Guo Z, Viitanen M, Fratiglioni L, Winbald B. Low blood pressure and dementia in elderly people: The Kungsholmen project. Br Med J 1996;312: 805-808.
139. Meyer JS, Judd BW, Tawaklna T et al. Improved cognition after control of risk factors for multi-infarct dementia. JAMA 1986;256:2203-2209.
140. Meyer JS, Rogers RL, McClintic K et al. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. J Am Geriatr Soc 1989;37:549-555.
141. Walzl M, Walzl B, Lechner H. Results of a two-month follow-up after a single heparin- induced extracorporeal LDL precipitation in vascular dementia. J Stroke Cerebrovasc Dis 1994;4:179-182.
142. European Pentoxifylline Multi-Infarct Dementia (EPMID) Study Group. European pen- toxifylline multi-infarct dementia study. Eur Neurol 1996; 36:315-321.
143. Marcusson J, Rother M, Kittner B et al. A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. Dement Geriatr Cogn Disord 1997;8:320-328.
144. Pantoni L, Carosi M, Amigoni S et al. A preliminary open trial with nimoipyine in patients with cognitive impairment and leukoaraiosis. Clin Neuropharmacol 1996;19:497-506.
145. Chandra B. Treatment of multi-infarct dementia with citicholine. J Stroke Cerebrovasc Dis 1992;2:232-233.
146. Nadeau SE, Malloy PF, Andrew ME. A crossover trial of bromocriptine in the treatment of vascular dementia. Ann Neurol 1988;24:270-272.
147. Khachaturian Z S, Radebaugh TS. Alzheimer's Disease Cause(s), Diagnosis, Treatment and Care. New York: CRC Press, 1996, pp 249-336.